0001083220--12-31 2024 Q3 false P6Y P4Y6M P25Y 2600000 0 23581290 19795053 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember 2024-04-12 0001083220 xelb:ImWhpLlcMember xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001083220 2024-07-31 2024-07-31 0001083220 xelb:ImTopcoMember xelb:AmendedServicesAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:ImTopcoMember xelb:AmendedServicesAgreementMember 2024-01-01 2024-09-30 0001083220 xelb:HalstonBrandMember srt:MinimumMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember srt:MaximumMember 2023-05-15 2023-05-15 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 2022-05-31 0001083220 2023-01-01 2023-12-31 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember 2024-04-12 2024-04-12 0001083220 xelb:ImWhpLlcMember xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember xelb:AmendedServicesAgreementMember 2024-04-12 2024-04-12 0001083220 xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember 2024-01-01 2024-09-30 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 2024-11-30 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-07-01 2024-09-30 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-01-01 2023-09-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2024-01-01 2024-09-30 0001083220 xelb:LoriGoldsteinBrandMember 2024-01-01 2024-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2021-04-01 2021-04-01 0001083220 xelb:LoriGoldsteinBrandMember 2024-09-30 0001083220 xelb:LoriGoldsteinBrandMember 2023-01-01 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-01-01 2022-12-31 0001083220 xelb:Lease1113BroadwayMember 2024-01-26 2024-01-26 0001083220 xelb:Lease550SeventhAvenueMember 2024-02-29 2024-02-29 0001083220 xelb:Lease1113BroadwayMember 2024-01-01 2024-09-30 0001083220 xelb:IpxCapitalLlcMember 2024-12-12 2024-12-12 0001083220 xelb:IpxCapitalLlcMember 2024-12-01 2024-12-31 0001083220 xelb:IpxCapitalLlcMember 2024-10-01 2024-10-31 0001083220 xelb:HalstonBrandMember 2023-05-15 2023-05-15 0001083220 xelb:HilcoGlobalMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2024-01-01 2024-09-30 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2024-01-01 2024-09-30 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001083220 xelb:ConsultantsMember 2023-04-01 2023-06-30 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 xelb:ConsultantsMember 2023-01-01 2023-03-31 0001083220 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001083220 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001083220 srt:DirectorMember us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001083220 srt:DirectorMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2024-09-30 0001083220 us-gaap:NoncontrollingInterestMember 2024-09-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001083220 us-gaap:RetainedEarningsMember 2024-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2024-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001083220 2024-06-30 0001083220 us-gaap:RetainedEarningsMember 2024-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2024-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001083220 2024-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001083220 us-gaap:RetainedEarningsMember 2023-09-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-09-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001083220 us-gaap:RetainedEarningsMember 2023-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001083220 2023-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001083220 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2024-07-01 2024-09-30 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001083220 xelb:ConsultantsMember 2024-01-01 2024-03-31 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001083220 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-07-01 2023-09-30 0001083220 us-gaap:CommonStockMember 2024-09-30 0001083220 us-gaap:CommonStockMember 2024-06-30 0001083220 us-gaap:CommonStockMember 2023-12-31 0001083220 us-gaap:CommonStockMember 2023-09-30 0001083220 us-gaap:CommonStockMember 2023-06-30 0001083220 us-gaap:CommonStockMember 2023-03-31 0001083220 us-gaap:CommonStockMember 2022-12-31 0001083220 us-gaap:PrivatePlacementMember 2024-03-14 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-12-31 0001083220 xelb:EquityIncentivePlan2021Member 2024-09-30 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2024-01-01 2024-09-30 0001083220 xelb:SeniorManagementMember us-gaap:CommonStockMember 2024-08-02 2024-08-02 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember 2024-04-03 2024-04-03 0001083220 xelb:ConsultantMember 2024-01-12 2024-01-12 0001083220 srt:ExecutiveOfficerMember us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:ShareBasedPaymentArrangementTrancheFourMember 2024-04-03 2024-04-03 0001083220 xelb:NonManagementDirectorsMember us-gaap:CommonStockMember xelb:April2026Member 2024-04-03 2024-04-03 0001083220 xelb:NonManagementDirectorsMember us-gaap:EmployeeStockOptionMember 2024-04-03 2024-04-03 0001083220 xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember 2024-09-30 0001083220 xelb:YearEndingDecember312025Member xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 xelb:TwelveMonthPeriodEndingMarch312025Member xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 srt:MaximumMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-07-01 2023-09-30 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-01-01 2023-09-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2024-07-01 2024-09-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2024-01-01 2024-09-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-07-01 2023-09-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-01-01 2023-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001083220 us-gaap:ProductMember 2024-07-01 2024-09-30 0001083220 us-gaap:LicenseMember 2024-07-01 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001083220 xelb:HalstonBrandMember 2024-01-01 2024-09-30 0001083220 us-gaap:ProductMember 2024-01-01 2024-09-30 0001083220 us-gaap:LicenseMember 2024-01-01 2024-09-30 0001083220 xelb:HalstonBrandMember 2023-07-01 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001083220 us-gaap:ProductMember 2023-07-01 2023-09-30 0001083220 us-gaap:LicenseMember 2023-07-01 2023-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001083220 xelb:HalstonBrandMember 2023-01-01 2023-09-30 0001083220 us-gaap:ProductMember 2023-01-01 2023-09-30 0001083220 us-gaap:LicenseMember 2023-01-01 2023-09-30 0001083220 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001083220 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001083220 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001083220 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001083220 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001083220 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001083220 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2024-06-30 2024-06-30 0001083220 xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 2024-03-15 0001083220 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001083220 us-gaap:PrivatePlacementMember 2024-03-14 2024-03-14 0001083220 xelb:PublicOfferingMember 2024-03-19 2024-03-19 0001083220 xelb:OrmeLiveMember 2023-12-01 2023-12-31 0001083220 xelb:ImTopcoMember xelb:AmendedServicesAgreementMember 2023-11-30 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2022-05-31 0001083220 xelb:Lease1113BroadwayMember 2024-09-30 0001083220 xelb:Lease550SeventhAvenueMember 2024-09-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-09-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:OrmeLiveMember 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2024-09-30 0001083220 xelb:OrmeLiveMember 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember 2024-07-01 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2024-01-01 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2023-07-01 2023-09-30 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-09-30 0001083220 xelb:OrmeLiveMember 2024-07-01 2024-09-30 0001083220 xelb:OrmeLiveMember 2024-01-01 2024-09-30 0001083220 xelb:Lease1113BroadwayMember xelb:RightOfUseAssetMember 2024-01-01 2024-09-30 0001083220 xelb:Lease1113BroadwayMember us-gaap:LeaseholdImprovementsMember 2024-01-01 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2024-07-01 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2024-01-01 2024-09-30 0001083220 xelb:IMTopcoLLCMember 2023-07-01 2023-09-30 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-09-30 0001083220 us-gaap:TrademarksMember 2024-09-30 0001083220 us-gaap:IntellectualPropertyMember 2024-09-30 0001083220 xelb:LoriGoldsteinBrandMember 2024-06-30 0001083220 us-gaap:TrademarksMember 2023-12-31 0001083220 us-gaap:IntellectualPropertyMember 2023-12-31 0001083220 xelb:OrmeLiveMember us-gaap:OtherAssetsMember 2024-09-30 0001083220 xelb:OrmeLiveMember us-gaap:OtherAssetsMember 2023-12-31 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2024-09-30 0001083220 xelb:XcelBrandsMember xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 xelb:XcelBrandsMember xelb:IMTopcoLLCMember xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember xelb:AmendedServicesAgreementMember 2024-04-12 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2022-05-31 0001083220 us-gaap:RestrictedStockMember 2024-01-01 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2024-09-30 0001083220 us-gaap:SwapMember 2023-10-19 0001083220 xelb:IsraelDiscountBankOfNewYorkMember us-gaap:SwapMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-19 0001083220 xelb:HalstonBrandMember 2024-09-30 0001083220 xelb:HalstonBrandMember 2023-12-31 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember 2024-12-12 2024-12-12 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 2023-10-19 0001083220 xelb:NewLoanAndSecurityAgreementMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-19 0001083220 us-gaap:SubsequentEventMember xelb:FirstEagleAlternativeCreditLlcMember 2024-12-31 0001083220 xelb:IpxCapitalLlcMember 2024-12-31 0001083220 xelb:IpxCapitalLlcMember us-gaap:SubsequentEventMember xelb:TermLoanbMember 2024-12-12 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember xelb:TermLoanbMember 2024-12-12 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember xelb:TermLoanaMember 2024-12-12 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember xelb:DelayedDrawTermLoanMember 2024-12-12 0001083220 xelb:NewLoanAndSecurityAgreementMember 2024-09-30 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember xelb:TermLoanbMember 2024-12-12 2024-12-12 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember xelb:TermLoanaMember 2024-12-12 2024-12-12 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001083220 xelb:AmericasCollectiblesNetworkInc.Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:AmericasCollectiblesNetworkInc.Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:HalstonBrandMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001083220 xelb:PublicOfferingMember 2024-03-19 0001083220 xelb:PublicOfferingMember 2024-03-15 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember 2024-11-30 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:SubsequentEventMember 2024-10-31 0001083220 us-gaap:RestrictedStockMember 2024-09-30 0001083220 us-gaap:CommonStockMember 2024-03-31 0001083220 srt:ExecutiveVicePresidentMember xelb:PublicOfferingMember 2024-03-19 0001083220 srt:DirectorMember xelb:PublicOfferingMember 2024-03-19 0001083220 srt:ChiefExecutiveOfficerMember xelb:PublicOfferingMember 2024-03-19 0001083220 xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 0001083220 xelb:AgreementsMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ExecutiveVicePresidentMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:DirectorMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 us-gaap:RestrictedStockMember 2023-12-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2021Member 2024-09-30 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2011Member 2024-09-30 0001083220 xelb:HalstonBrandMember xelb:NotRelatedToPlanMember 2024-09-30 0001083220 us-gaap:WarrantMember xelb:NotRelatedToPlanMember 2024-09-30 0001083220 xelb:NotRelatedToPlanMember 2024-09-30 0001083220 xelb:EquityIncentivePlansMember 2024-09-30 0001083220 us-gaap:WarrantMember 2024-09-30 0001083220 us-gaap:WarrantMember 2023-12-31 0001083220 xelb:IpxCapitalLlcMember us-gaap:SubsequentEventMember 2024-12-03 0001083220 xelb:FirstEagleAlternativeCreditLlcMember us-gaap:SubsequentEventMember 2024-12-12 0001083220 us-gaap:WarrantMember 2024-03-19 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 0001083220 2022-12-31 0001083220 2023-09-30 0001083220 xelb:ImWhpLlcMember xelb:IMTopcoLLCMember 2024-09-30 0001083220 xelb:LoriGoldsteinBrandMember 2024-09-30 0001083220 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001083220 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001083220 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001083220 xelb:EmployeeMember 2024-07-01 2024-09-30 0001083220 xelb:DirectorAndConsultantsMember 2024-07-01 2024-09-30 0001083220 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001083220 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001083220 xelb:EmployeeMember 2024-01-01 2024-09-30 0001083220 xelb:DirectorAndConsultantsMember 2024-01-01 2024-09-30 0001083220 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001083220 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001083220 xelb:DirectorAndConsultantsMember 2023-07-01 2023-09-30 0001083220 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001083220 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001083220 xelb:EmployeeMember 2023-01-01 2023-09-30 0001083220 xelb:DirectorAndConsultantsMember 2023-01-01 2023-09-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001083220 2023-01-01 2023-09-30 0001083220 xelb:LoriGoldsteinBrandMember 2024-01-01 2024-09-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001083220 2024-07-01 2024-09-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001083220 2024-04-01 2024-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001083220 2024-01-01 2024-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001083220 2023-07-01 2023-09-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001083220 2023-04-01 2023-06-30 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-09-30 0001083220 xelb:AmericasCollectiblesNetworkInc.Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-09-30 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001083220 xelb:AmericasCollectiblesNetworkInc.Member us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001083220 2024-09-30 0001083220 2023-12-31 0001083220 2024-12-15 0001083220 2024-01-01 2024-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure xelb:item

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 10-Q

​

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended September 30, 2024

or

​

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

​

For the transition period from ___ to ___

​

Commission File Number: 001-37527

​

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

​

Delaware |  | 76-0307819
(State or Other Jurisdiction of |  | (I.R.S. Employer
Incorporation or Organization) |  | Identification No.)

​

​

| 550 Seventh Avenue, 11th Floor, New York, NY 10018 |
| (Address of Principal Executive Offices) |

​

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Common Stock, $0.001 par value per share | ​ | XELB | ​ | NASDAQ Capital Market

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​ | ​
Large accelerated filer ☐ | Accelerated filer ☐
Non-accelerated filer ☒ | Smaller reporting company ☒
| Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

​

As of December 15, 2024, there were 23,639,973 shares of common stock, $.001 par value per share, of the issuer outstanding.

​

​

​

​

Table of Contents

XCEL BRANDS, INC.

INDEX

​ | a |
​ | ​ | Page
​ | ​ | ​
PART I - FINANCIAL INFORMATION | 3
​ | ​ | ​
Item 1. | Financial Statements | 3
​ | ​ | ​
​ | Unaudited Condensed Consolidated Balance Sheets | 3
​ | ​ | ​
​ | Unaudited Condensed Consolidated Statements of Operations | 4
​ | ​ | ​
​ | Unaudited Condensed Consolidated Statements of Stockholders’ Equity | 5
​ | ​ | ​
​ | Unaudited Condensed Consolidated Statements of Cash Flows | 6
​ | ​ | ​
​ | Notes to Unaudited Condensed Consolidated Financial Statements | 7
​ | ​ | ​
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 27
​ | ​ | ​
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 39
​ | ​ | ​
Item 4. | Controls and Procedures | 39
​ | ​ | ​
PART II - OTHER INFORMATION | 41
​ | ​ | ​
Item 1. | Legal Proceedings | 41
​ | ​ | ​
Item 1A. | Risk Factors | 41
​ | ​ | ​
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42
​ | ​ | ​
Item 3. | Defaults Upon Senior Securities | 42
​ | ​ | ​
Item 4. | Mine Safety Disclosures | 42
​ | ​ | ​
Item 5. | Other Information | 43
​ | ​ | ​
Item 6. | Exhibits | 43
​ | ​ | ​
​ | Signatures | 43

​

​

2

Table of Contents

PART I. FINANCIAL INFORMATION

​

ITEM 1. FINANCIAL STATEMENTS

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, 2024 |  | December 31, 2023
​ | ​ | (Unaudited) | ​ | (Note 1)
Assets |  | ​ |  |  | ​ |
Current Assets: |  | ​ |  |  | ​ |
Cash and cash equivalents | ​ | $ | 242 | ​ | $ | 2,998
Accounts receivable, net of allowances for credit losses of $30 and $75 at September 30, 2024 and December 31, 2023, respectively | ​ |  | 2,908 | ​ |  | 3,454
Inventory | ​ |  | — | ​ |  | 453
Prepaid expenses and other current assets | ​ |  | 375 | ​ |  | 398
Total current assets | ​ |  | 3,525 | ​ |  | 7,303
Non-current Assets: | ​ | ​ | ​ | ​ | ​ | ​
Property and equipment, net | ​ |  | 202 | ​ |  | 634
Operating lease right-of-use assets | ​ | ​ | 3,923 | ​ | ​ | 4,453
Trademarks and other intangibles, net | ​ |  | 35,642 | ​ |  | 41,520
Equity method investments, net | ​ | ​ | 9,796 | ​ | ​ | 17,735
Other assets | ​ |  | 911 | ​ |  | 15
Total non-current assets | ​ |  | 50,474 | ​ |  | 64,357
​ | ​ | ​ | ​ | ​ | ​ | ​
Total Assets | ​ | $ | 53,999 | ​ | $ | 71,660
​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities and Stockholders' Equity | ​ |  |  | ​ |  |
Current Liabilities: | ​ |  |  | ​ |  |
Accounts payable, accrued expenses and other current liabilities | ​ | $ | 2,602 | ​ | $ | 2,236
Deferred revenue | ​ |  | 1,376 | ​ |  | 889
Accrued income taxes payable | ​ | ​ | 372 | ​ | ​ | 372
Current portion of operating lease obligations | ​ | ​ | 1,433 | ​ | ​ | 1,258
Current portion of long-term debt | ​ |  | 1,000 | ​ |  | 750
Current portion of contingent obligations | ​ |  | — | ​ |  | 964
Total current liabilities | ​ |  | 6,783 | ​ |  | 6,469
Long-Term Liabilities: | ​ |  |  | ​ |  |
Deferred revenue | ​ | ​ | 2,889 | ​ | ​ | 3,556
Long-term portion of operating lease obligations | ​ | ​ | 5,633 | ​ | ​ | 4,021
Long-term debt, net, less current portion | ​ |  | 3,297 | ​ |  | 3,971
Long-term portion of contingent obligation | ​ | ​ | — | ​ | ​ | 5,432
Other long-term liabilities | ​ |  | 431 | ​ |  | 40
Total long-term liabilities | ​ |  | 12,250 | ​ |  | 17,020
Total Liabilities | ​ |  | 19,033 | ​ |  | 23,489
​ | ​ | ​ | ​ | ​ | ​ | ​
Commitments and Contingencies | ​ |  |  | ​ |  |
​ | ​ | ​ | ​ | ​ | ​ | ​
Stockholders' Equity: | ​ |  |  | ​ |  |
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding | ​ |  | — | ​ |  | —
Common stock, $.001 par value, 50,000,000 shares authorized, and 23,581,290 and 19,795,053 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | ​ |  | 24 | ​ |  | 20
Paid-in capital | ​ |  | 106,056 | ​ |  | 103,861
Accumulated deficit | ​ |  | (69,161) | ​ |  | (53,849)
Total Xcel Brands, Inc. stockholders' equity | ​ |  | 36,919 | ​ |  | 50,032
Noncontrolling interest | ​ | ​ | (1,953) | ​ | ​ | (1,861)
Total Stockholders' Equity | ​ |  | 34,966 | ​ |  | 48,171
​ | ​ | ​ | ​ | ​ | ​ | ​
Total Liabilities and Stockholders' Equity | ​ | $ | 53,999 | ​ | $ | 71,660

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

3

Table of Contents

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Revenues |  | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |
Net licensing revenue | ​ | $ | 1,505 | ​ | $ | 2,381 | ​ | $ | 6,515 | ​ | $ | 7,031
Net sales | ​ |  | 407 | ​ |  | 256 | ​ |  | 535 | ​ |  | 8,437
Net revenue | ​ |  | 1,912 | ​ |  | 2,637 | ​ |  | 7,050 | ​ |  | 15,468
Cost of goods sold | ​ |  | 407 | ​ |  | 225 | ​ |  | 445 | ​ |  | 6,718
Gross profit | ​ |  | 1,505 | ​ |  | 2,412 | ​ |  | 6,605 | ​ |  | 8,750
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Direct operating costs and expenses | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Salaries, benefits and employment taxes | ​ |  | 1,208 | ​ |  | 2,141 | ​ |  | 4,771 | ​ |  | 7,847
Other selling, general and administrative expenses | ​ |  | 1,618 | ​ |  | 3,482 | ​ |  | 5,137 | ​ |  | 9,918
Total direct operating costs and expenses | ​ |  | 2,826 | ​ |  | 5,623 | ​ |  | 9,908 | ​ |  | 17,765
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating loss before other operating costs and expenses (income) | ​ | ​ | (1,321) | ​ | ​ | (3,211) | ​ | ​ | (3,303) | ​ | ​ | (9,015)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other operating costs and expenses (income) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ |  | 910 | ​ |  | 1,677 | ​ |  | 4,044 | ​ |  | 5,260
Asset impairment charges | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 3,483 | ​ | ​ | —
Loss from equity method investments | ​ | ​ | 593 | ​ | ​ | 515 | ​ | ​ | 1,683 | ​ | ​ | 1,545
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 6,254 | ​ | ​ | — | ​ | ​ | 6,254 | ​ | ​ | —
Gain on divestiture of Lori Goldstein Brand | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (3,801) | ​ | ​ | —
Gain on sale of limited partner ownership interest | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (351)
Gain on settlement of lease liability | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (445)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating loss | ​ |  | (9,078) | ​ |  | (5,403) | ​ |  | (14,966) | ​ |  | (15,024)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest and finance expense (income), net | ​ |  | 142 | ​ |  | — | ​ |  | 438 | ​ |  | 18
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Loss before income taxes | ​ |  | (9,220) | ​ |  | (5,403) | ​ |  | (15,404) | ​ |  | (15,042)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income tax benefit | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | ​ | (9,220) | ​ | ​ | (5,403) | ​ | ​ | (15,404) | ​ | ​ | (15,042)
Net loss attributable to noncontrolling interest | ​ | ​ | (7) | ​ | ​ | (259) | ​ | ​ | (92) | ​ | ​ | (787)
Net loss attributable to Xcel Brands, Inc. stockholders | ​ | $ | (9,213) | ​ | $ | (5,144) | ​ | $ | (15,312) | ​ | $ | (14,255)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings (loss) per common share attributable to Xcel Brands, Inc. stockholders: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Basic earnings (loss) per share | ​ | $ | (0.39) | ​ | $ | (0.26) | ​ | $ | (0.68) | ​ | $ | (0.72)
Diluted earnings (loss) per share | ​ | $ | (0.39) | ​ | $ | (0.26) | ​ | $ | (0.68) | ​ | $ | (0.72)
Weighted average number of common shares outstanding: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Basic weighted average common shares outstanding | ​ |  | 23,522,453 | ​ |  | 19,749,317 | ​ |  | 22,466,737 | ​ |  | 19,683,525
Diluted weighted average common shares outstanding | ​ |  | 23,522,453 | ​ |  | 19,749,317 | ​ |  | 22,466,737 | ​ |  | 19,683,525

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

4

Table of Contents

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Xcel Brands, Inc. Stockholders | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Number of | ​ | ​ | ​ | ​ | Paid-In | ​ | Accumulated | ​ | Noncontrolling | ​ | ​ | ​
​ |  | Shares |  | Amount |  | Capital |  | Deficit |  | Interest | ​ | ​ | Total
Balance as of December 31, 2022 |  | 19,624,860 | ​ | $ | 20 | ​ | $ | 103,592 | ​ | $ | (32,797) | ​ | $ | (676) | ​ | ​ | $ | 70,139
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 51 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 51
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to consultant in connection with stock grant | ​ | 8,334 | ​ | ​ | — | ​ | ​ | 6 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 6
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss |  | — | ​ |  | — | ​ |  | — | ​ |  | (5,643) | ​ | ​ | (295) | ​ | ​ |  | (5,938)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of March 31, 2023 |  | 19,633,194 | ​ | ​ | 20 | ​ | ​ | 103,649 | ​ | ​ | (38,440) | ​ | ​ | (971) | ​ | ​ | ​ | 64,258
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 27 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 27
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to consultant in connection with stock grant | ​ | 58,334 | ​ | ​ | — | ​ | ​ | 39 | ​ | ​ | — | ​ |  | — | ​ | ​ | ​ | 39
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued on exercise of stock options, net of shares surrendered for cashless exercises | ​ | 9,128 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) |  | — | ​ |  | — | ​ |  | — | ​ |  | (3,468) | ​ |  | (233) | ​ | ​ |  | (3,701)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of June 30, 2023 |  | 19,700,656 | ​ | ​ | 20 | ​ | ​ | 103,715 | ​ | ​ | (41,908) | ​ | ​ | (1,204) | ​ | ​ | ​ | 60,623
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 36 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 36
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contra-revenue related to warrants held by licensee | ​ | — | ​ | ​ | — | ​ | ​ | 16 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 16
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to directors in connection with restricted stock grants | ​ | 40,000 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to employee in connection with stock grant | ​ | 7,300 | ​ | ​ | — | ​ | ​ | 10 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 10
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued on exercise of stock options, net of shares surrendered for cashless exercises | ​ | 52,097 | ​ | ​ | — | ​ | ​ | 27 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 27
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (5,144) | ​ | ​ | (259) | ​ | ​ | ​ | (5,403)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of September 30, 2023 | ​ | 19,800,053 | ​ | $ | 20 | ​ | $ | 103,804 | ​ | $ | (47,052) | ​ | $ | (1,463) | ​ | ​ | $ | 55,309
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of December 31, 2023 |  | 19,795,053 | ​ | $ | 20 | ​ | $ | 103,861 | ​ | $ | (53,849) | ​ | $ | (1,861) | ​ | ​ | $ | 48,171
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 36 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 36
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contra-revenue related to warrants held by licensee | ​ | — | ​ | ​ | — | ​ | ​ | 10 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 10
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to consultant in connection with stock grant |  | 78,000 | ​ |  | — | ​ |  | 98 | ​ |  | — | ​ |  | — | ​ | ​ |  | 98
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued in connection with public offering and private placement transactions, net of transaction costs | ​ | 3,579,064 | ​ | ​ | 3 | ​ | ​ | 1,899 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 1,902
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss |  | — | ​ |  | — | ​ |  | — | ​ |  | (6,294) | ​ | ​ | (51) | ​ | ​ |  | (6,345)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of March 31, 2024 |  | 23,452,117 | ​ | ​ | 23 | ​ | ​ | 105,904 | ​ | ​ | (60,143) | ​ | ​ | (1,912) | ​ | ​ | ​ | 43,872
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 32 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 32
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contra-revenue related to warrants held by licensee |  | — | ​ |  | — | ​ |  | 10 | ​ |  | — | ​ |  | — | ​ | ​ |  | 10
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to directors in connection with restricted stock grants | ​ | 40,000 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) |  | — | ​ |  | — | ​ |  | — | ​ |  | 195 | ​ |  | (34) | ​ | ​ |  | 161
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of June 30, 2024 |  | 23,492,117 | ​ | ​ | 23 | ​ | ​ | 105,946 | ​ | ​ | (59,948) | ​ | ​ | (1,946) | ​ | ​ | ​ | 44,075
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Compensation expense related to stock options and restricted stock | ​ | — | ​ | ​ | — | ​ | ​ | 37 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 37
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contra-revenue related to warrants granted to licensee | ​ | — | ​ | ​ | — | ​ | ​ | 9 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 9
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to employee in connection with stock grant | ​ | 14,685 | ​ | ​ | — | ​ | ​ | 10 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 10
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issued to executives for pro rata portion of base salaries, net of withholding taxes | ​ | 74,488 | ​ | ​ | 1 | ​ | ​ | 54 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | 55
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (9,213) | ​ | ​ | (7) | ​ | ​ | ​ | (9,220)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance as of September 30, 2024 | ​ | 23,581,290 | ​ | $ | 24 | ​ | $ | 106,056 | ​ | $ | (69,161) | ​ | $ | (1,953) | ​ | ​ | $ | 34,966

​

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

5

Table of Contents

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Nine Months Ended September 30,
​ |  | 2024 |  | 2023
Cash flows from operating activities |  | ​ |  |  | ​ |
Net loss | ​ | $ | (15,404) | ​ | $ | (15,042)
Adjustments to reconcile net loss to net cash used in operating activities: | ​ |  | ​ | ​ |  |
Depreciation and amortization expense | ​ |  | 4,044 | ​ |  | 5,260
Asset impairment charges | ​ |  | 3,483 | ​ |  | 100
Amortization of deferred finance costs included in interest expense | ​ |  | 76 | ​ |  | —
Stock-based compensation and cost of licensee warrants | ​ |  | 296 | ​ |  | 184
Provision for (recovery of) credit losses | ​ | ​ | (45) | ​ | ​ | 20
Restructuring of certain contractual arrangements | ​ | ​ | — | ​ | ​ | 756
Undistributed proportional share of net loss of equity method investees | ​ | ​ | 1,683 | ​ | ​ | 1,545
Change in contingent obligation related to equity method investee | ​ | ​ | 6,254 | ​ | ​ | —
Gain on divestiture of Lori Goldstein brand | ​ | ​ | (3,801) | ​ | ​ | —
Gain on sale of limited partner ownership interest | ​ | ​ | — | ​ | ​ | (351)
Gain on settlement of lease liability | ​ | ​ | — | ​ | ​ | (445)
Changes in operating assets and liabilities: | ​ |  | ​ | ​ |  | ​
Accounts receivable | ​ |  | 591 | ​ |  | (415)
Inventory | ​ |  | 453 | ​ |  | 1,848
Prepaid expenses and other current and non-current assets | ​ |  | (134) | ​ |  | 920
Deferred revenue | ​ | ​ | (180) | ​ | ​ | 4,676
Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities | ​ |  | (304) | ​ |  | (1,395)
Lease-related assets and liabilities | ​ | ​ | (710) | ​ | ​ | (471)
Other long-term liabilities | ​ |  | 391 | ​ |  | —
Net cash used in operating activities | ​ |  | (3,307) | ​ |  | (2,810)
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash flows from investing activities | ​ |  |  | ​ |  |
Net proceeds from sale of assets | ​ | ​ | — | ​ | ​ | 451
Purchase of property and equipment | ​ |  | (112) | ​ |  | (87)
Net cash (used in) provided by investing activities | ​ |  | (112) | ​ |  | 364
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash flows from financing activities | ​ |  |  | ​ |  |
Proceeds from exercise of stock options | ​ | ​ | — | ​ | ​ | 27
Proceeds from public offering and private placement transactions, net of transaction costs | ​ | ​ | 1,902 | ​ | ​ | —
Shares repurchased including vested restricted stock in exchange for withholding taxes | ​ | ​ | — | ​ |  | —
Payment of long-term debt | ​ |  | (500) | ​ |  | —
Net cash provided by financing activities | ​ |  | 1,402 | ​ |  | 27
​ | ​ | ​ | ​ | ​ | ​ | ​
Net decrease in cash, cash equivalents, and restricted cash | ​ |  | (2,017) | ​ |  | (2,419)
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash, cash equivalents, and restricted cash at beginning of period | ​ | ​ | 2,998 | ​ | ​ | 4,608
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash, cash equivalents, and restricted cash at end of period | ​ | $ | 981 | ​ | $ | 2,189
​ | ​ | ​ | ​ | ​ | ​ | ​
Reconciliation to amounts on consolidated balance sheets: | ​ |  |  | ​ |  |
Cash and cash equivalents | ​ | $ | 242 | ​ | $ | 2,189
Restricted cash (reported in other non-current assets) | ​ |  | 739 | ​ |  | —
Total cash, cash equivalents, and restricted cash | ​ | $ | 981 | ​ | $ | 2,189
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of non-cash activities: | ​ | ​ | ​ | ​ | ​ | ​
Recognition of operating lease right-of-use asset | ​ | $ | 2,596 | ​ | $ | —
Recognition of operating lease obligation | ​ | $ | 2,596 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of cash flow information: | ​ |  |  | ​ |  |
Cash paid during the period for interest | ​ | $ | 344 | ​ | $ | —
Cash paid during the period for income taxes | ​ | $ | — | ​ | $ | 16

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

​

6

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024.

The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

| ● | The Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.

| ● | The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.

| ● | The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

| ● | The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and launched in May 2024.

The Company’s brand portfolio also included the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”) as a wholly owned brand from April 1, 2021 through June 30, 2024; the Lori Goldstein Brand was divested on June 30, 2024 (see Note 3 for additional details).

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that launched in April 2024.

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues. The only net sales and cost of goods sold recognized for the nine months ended September 30, 2024 were (i) the final sale of certain residual jewelry inventories during the three months ended June 30, 2024 and (ii) the sale of all remaining inventory related to the Longaberger Brand during the three months ended September 30, 2024. As of September 30, 2024, the Company has no remaining inventory.

Liquidity and Management’s Plans

The Company incurred a net loss attributable to Company stockholders of approximately $15.3 million during the nine months ended September 30, 2024 (which included non-cash expenses of approximately $15.8 million and a $3.80 million non-cash gain on the divestiture of the Lori Goldstein Brand), and had an accumulated deficit of approximately $69.2 million as of September 30, 2024. Net cash used in operating activities was approximately $3.3 million for the nine months ended September 30, 2024, of which $2.6 million of the cash used in operating activities was attributable to the three months ended March 31, 2024. The Company had unrestricted cash and cash equivalents of approximately $0.2 million as of September 30, 2024, and a working capital deficit (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in shares) of approximately $(0.4) million as of September 30, 2024.

​

The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern. However, in December 2024, the Company entered into a new term loan agreement for an aggregate amount of $10 million, which provides the Company with approximately $3.5 million of additional liquidity after repayment of the previous term loan (see Note 13 for additional details). In connection with the new term loan debt, Company’s working capital increased by approximately $4.5 million subsequent to September 30, 2024.

​

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. These restructuring initiatives included entering into various new licensing agreements and joint venture arrangements with best-in-class business partners, and reducing the Company’s payroll, overhead, and other operating costs by approximately $15 million on an annualized basis when compared to 2022.

During the first nine months of 2024, management took further actions to optimize its cost structure and manage its liquidity, including entering into a divestiture transaction (see Note 3 for details) which eliminated certain operating and compensation expenses, relieved the Company of its contractual obligations to make future cash payments of approximately $1 million, and relieved the Company of a potential future contingent obligation to make future cash payments of up to approximately $11 million. As of the third quarter of 2024, the Company has reduced its direct operating expenses to a current run rate of approximately $11 million per annum. Also during the first nine months of 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

and uncertainties with respect to the Company’s ability to continue as a going concern as of September 30, 2024 have been alleviated.

​

​

2. Investments in Unconsolidated Affiliates and Variable Interest Entities

​

Investment in IM Topco, LLC

On May 31, 2022, Xcel sold 70% of the membership interests of IM Topco, LLC (“IM Topco”), a former subsidiary which holds the trademarks and other intellectual property rights relating to the Isaac Mizrahi Brand, to a subsidiary of WHP Global (“WHP”), a private equity-backed brand management and licensing company.

The Company accounts for its 30% retained interest in the ongoing operations of IM Topco as a component of other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

| (i) | first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);

| (ii) | second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and

| (iii) | thereafter, in proportion to the members’ respective percentage interests.

Further, on April 12, 2024, the Company, WHP, and IM Topco entered into an amendment of the business venture agreement, such that on and after January 1, 2026, WHP shall receive 50% of the net cash flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional net cash flow equal to $1,000,000.

Based on these distribution provisions, the Company recognized an equity method loss related to its investment in IM Topco of $0.52 million for each of the three-month periods ended September 30, 2024 and 2023, and $1.55 million for each of the nine-month periods ended September 30, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for all of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal to Xcel’s share of amortization expense.

Summarized financial information for IM Topco for the three and nine months ended September 30, 2024 and 2023 is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | For the three months ended | ​ | For the nine months ended
​ | ​ | September 30, | ​ | September 30,
($ in thousands) | ​ | 2024 | ​ | 2023 | ​ | 2024 | ​ | 2023
Revenues | ​ | $ | 1,952 | ​ | $ | 3,219 | ​ | $ | 7,133 | ​ | $ | 9,819
Gross profit | ​ | ​ | 1,952 | ​ | ​ | 3,219 | ​ | ​ | 7,133 | ​ | ​ | 9,819
Loss from continuing operations | ​ | ​ | (1,139) | ​ | ​ | (91) | ​ | ​ | (2,212) | ​ | ​ | (348)
Net loss | ​ | ​ | (1,139) | ​ | ​ | (91) | ​ | ​ | (2,212) | ​ | ​ | (348)

​

Purchase Price Adjustment: In accordance with the May 31, 2022 membership interest purchase agreement, as amended, WHP (as buyer) may be entitled to receive from Xcel 12.5% of the total outstanding equity interests of IM Topco if, during

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

the twelve-month period ending March 31, 2025, IM Topco receives less than $13.5 million in aggregate royalties (the “Purchase Price Adjustment”). Based on current trends and projections of IM Topco’s revenues, the Company estimates that there is high likelihood that IM Topco’s revenues will be less than the required minimum and the Company will be obligated to transfer the required membership interests to WHP in accordance with the Purchase Price Adjustment. The Company has recorded a contingent obligation of approximately $6.3 million as a reduction to the carrying value of the equity method investment as of September 30, 2024, based on the expected March 31, 2025 value of the potential transferred membership interest.

​

Refer to Note 11 and Note 12 for additional information regarding the Company’s ongoing relationship with IM Topco.

​

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment was $0.01 million and $0.15 million as of September 30, 2024 and December 31, 2023, respectively.

The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three and nine months ended September 30, 2024 was a loss of approximately $0.08 million and $0.14 million, respectively.

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

​

​

3. Divestiture Transaction

On June 21, 2024, the Company (through its wholly owned subsidiary, Gold Licensing, LLC) entered into an asset purchase agreement with Lori Goldstein and Lori Goldstein, Ltd (together the “LG Parties”), pursuant to which the Company agreed to sell, and the LG Parties agreed to purchase, substantially all of the assets of the Lori Goldstein Brand, including the “LOGO by Lori Goldstein” trademark and other intellectual property rights relating thereto. Also in conjunction with this transaction, key license agreements related to the Lori Goldstein Brand were assigned to and assumed by the LG Parties. This divestiture transaction closed on June 30, 2024.

​

As consideration for the sale of these assets, the parties agreed to the following:

​

| ● | The LG Parties waived their rights with respect to certain contingent consideration amounts that had been previously earned by the LG Parties (under the terms of the April 1, 2021 purchase of the assets by Xcel), and terminated their rights to any future earn-out payments.

​

| ● | The Company retained the right to all royalties and fee income for net sales from licensees related to the Lori Goldstein Brand through the closing date.

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

​

| ● | The Company’s May 2, 2024 termination of the employment agreement and consulting agreement with the LG Parties was withdrawn and stayed until the closing date. The Company paid Ms. Goldstein and Lori Goldstein, Ltd a combined total of $25,000 as compensation for services rendered under the employment agreement and consulting agreement through June 30, 2024, and also reimbursed Ms. Goldstein for expenses incurred in the course of fulfilling her duties under the employment agreement through June 30, 2024.

​

| ● | The Company and the LG Parties entered into a mutual general release and waiver of outstanding legal disputes.

​

Thus, the total consideration received by the Company for this divestiture transaction was approximately $6.08 million, comprised of (i) the waiver of approximately $1.03 million of accrued earn-out payments earned by the LG Parties through June 30, 2024, plus (ii) the release of the remaining balance of approximately $5.05 million of contingent obligations recorded on the Company’s balance sheet. The remaining unamortized net book value of the Lori Goldstein intangible assets immediately prior to the sale was approximately $1.93 million, and the Company also incurred approximately $0.35 million of legal fees in connection with this transaction. Accordingly, the Company recorded a net non-cash gain on the divestiture of the Lori Goldstein Brand of approximately $3.80 million for the nine months ended September 30, 2024.

​

4. Trademarks and Other Intangibles

Trademarks and other intangibles, net consist of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Weighted |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
​ |  | Average |  | September 30, 2024
​ |  | Amortization | ​ | Gross Carrying | ​ | Accumulated | ​ | Net Carrying
($ in thousands) | ​ | Period | ​ | Amount | ​ | Amortization | ​ | Amount
Trademarks (finite-lived) |  | 15 years | ​ |  | 58,580 | ​ |  | 22,976 | ​ |  | 35,604
Copyrights and other intellectual property |  | 8 years | ​ |  | 429 | ​ |  | 391 | ​ |  | 38
Total | ​ | ​ | ​ | $ | 59,009 | ​ | $ | 23,367 | ​ | $ | 35,642

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Weighted |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
​ |  | Average |  | December 31, 2023
​ |  | Amortization |  | Gross Carrying | ​ | Accumulated | ​ | Net Carrying
($ in thousands) | ​ | Period | ​ | Amount | ​ | Amortization | ​ | Amount
Trademarks (finite-lived) |  | 15 years | ​ |  | 68,880 | ​ |  | 27,431 | ​ |  | 41,449
Copyrights and other intellectual property |  | 8 years | ​ |  | 429 | ​ |  | 358 | ​ |  | 71
Total |  |  | ​ | $ | 69,309 | ​ | $ | 27,789 | ​ | $ | 41,520

​

Amortization expense for intangible assets was approximately $0.89 million for the three-month period ended September 30, 2024 (the "current quarter") and approximately $1.53 million for the three-month period ended September 30, 2023 (the "prior year quarter").

​

Amortization expense for intangible assets was approximately $3.95 million for the nine-month period ended September 30, 2024 (the "current nine months") and approximately $4.60 million for the nine-month period ended September 30, 2023 (the "prior year nine months").

​

On June 30, 2024, the Company sold certain trademarks with a net book value of approximately $1.93 million (gross carrying amount of $10.30 million and accumulated amortization of approximately $8.37 million) related to the Lori Goldstein Brand (see Note 3 for additional details).

​

​

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

Estimated future amortization expense related to finite-lived intangible assets over the remaining useful lives is as follows:

​ | ​ | ​ | ​
($ in thousands) | ​ | Amortization
Year Ending December 31, |  | Expense
2024 (October 1 through December 31) | ​ | $ | 884
2025 |  | ​ | 3,531
2026 |  | ​ | 3,506
2027 |  | ​ | 3,503
2028 |  | ​ | 3,503
Thereafter (through 2036) |  | ​ | 20,715
Total | ​ | $ | 35,642

​

​

5. Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $0.26 million and $1.51 million for the current quarter and prior year quarter, respectively, representing approximately 14% and 57% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

Net licensing revenue from the Qurate Agreements totaled $3.27 million and $4.80 million for the current nine months and prior year nine months, respectively, representing approximately 46% and 31% of the Company’s total net revenue for the current nine months and prior year nine months, respectively.

As of September 30, 2024 and December 31, 2023, the Company had receivables from Qurate of $0.27 million and $1.3 million, respectively, representing approximately 9% and 37% of the Company’s total net accounts receivable, respectively.

​

Due to the divestiture of the Lori Goldstein Brand on June 30, 2024 (see Note 3 for details), the Company’s total net revenue and accounts receivable, as well as the relative proportional share of total net revenue and total accounts receivable attributable to the Qurate Agreements, have decreased; however, due to the Company’s other brands, management expects that Qurate will remain a significant licensee.

​

Halston Master License

On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $3.8 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023, respectively. As of December 31, 2023, approximately $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of September 30, 2024, approximately $0.9 million of the contract liability balance was classified as a current liability and approximately $2.9 million was classified as a long-term liability; the balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 4.25 years.

Net licensing revenue recognized from the Halston Master License was $0.64 million for both the current quarter and prior year quarter, representing approximately 33% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

​

Net licensing revenue recognized from the Halston Master License was $1.93 million and $0.98 million for the current nine months and prior year nine months, respectively, representing approximately 27% and 6% of the Company’s total net revenue for the current nine months and prior year nine months, respectively.

​

JTV / America’s Collectibles Network, Inc.

The Company has a license agreement with America’s Collectibles Network, Inc. (d/b/a JTV) (“JTV”) that obligates JTV to pay the Company royalties based on product sales of Judith Ripka Brand merchandise. In addition, the Company has outstanding receivables from prior product sales of fine jewelry made to JTV. As of September 30, 2024 and December 31, 2023, the Company had receivables from JTV of $1.31 million and $1.37 million, respectively, representing approximately 45% and 40% of the Company’s total net accounts receivable, respectively.

​

6. Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

Lease expense (net of sublease income of approximately $0.2 and $0.5 million for the current quarter and current nine months, respectively) included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.3 million for the current quarter, approximately $0.4 million for the prior year quarter, approximately $0.7 million for the current nine months, and approximately $1.2 million for the prior year nine months.

Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter, and approximately $1.2 million in both the current nine months and prior year nine months.

As of September 30, 2024, the Company’s real estate leases have a weighted-average remaining lease term of approximately 4.82 years, and the lease liabilities are measured using a weighted-average discount rate of 7.78%.

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

1333 Broadway Lease

The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized non-cash impairment charges of approximately $3.1 million during the current nine months related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current nine months related to leasehold improvement assets at this location.

As of September 30, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.08 years.

550 Seventh Avenue Lease

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year.

Upon commencement of the lease during the current quarter, the Company recognized a right-of-use asset and corresponding lease liability related to this lease of approximately $2.6 million; the discount rate used for the measurement of this right-of-use asset and lease liability was based on the Company’s incremental borrowing rate of 9.60%.

As of September 30, 2024, the Company’s lease of 550 Seventh Avenue has a remaining minimum lease term of approximately 7.58 years.

Future Lease Obligations

As of September 30, 2024, the maturities of future lease obligations were as follows:

​

​ | ​ | ​ | ​
​ | ​ | Amount
Year |  | (in thousands)
2024 (October 1 through December 31) | ​ | $ | 388
2025 | ​ | ​ | 1,926
2026 | ​ |  | 2,060
2027 | ​ |  | 1,841
2028 | ​ |  | 570
Thereafter | ​ |  | 2,005
Total lease payments | ​ | ​ | 8,790
Less: Discount | ​ | ​ | 1,724
Present value of lease liabilities | ​ | ​ | 7,066
Current portion of lease liabilities | ​ | ​ | 1,433
Non-current portion of lease liabilities | ​ | $ | 5,633

​

​

​

​

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

​

7. Debt

The Company’s net carrying amount of debt is comprised of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
($ in thousands) |  | 2024 |  | 2023
Term loan debt | ​ | $ | 4,500 | ​ | $ | 5,000
Unamortized deferred finance costs related to term loan debt | ​ |  | (203) | ​ |  | (279)
Total | ​ |  | 4,297 | ​ |  | 4,721
Current portion of debt | ​ |  | 1,000 | ​ |  | 750
Long-term debt | ​ | $ | 3,297 | ​ | $ | 3,971

​

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

​

In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement. Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

​

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

​

As of September 30, 2024, the aggregate remaining principal payments under the term loan were as follows:

​

​ | ​ | ​ | ​
​ | ​ | Amount of
($ in thousands) |  | Principal
Year Ending December 31, |  | Payment
2024 (October 1 through December 31) | ​ | $ | 250
2025 | ​ |  | 1,000
2026 | ​ | ​ | 1,000
2027 | ​ | ​ | 1,000
2028 | ​ |  | 1,250
Total | ​ | $ | 4,500

​

Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of September 30, 2024 and December 31, 2023.

​

For the current quarter and current nine months, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.13 million and $0.42 million, respectively, reflecting an effective interest rate of approximately 11.6%.

The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

​

8. Stockholders’ Equity

​

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

​

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized for all forms of stock-based compensation was approximately $0.15 million and $0.05 million for the current quarter and prior year quarter, respectively. Of the current quarter expense amount, approximately $0.11 million related to employees and approximately $0.04 million related to directors and consultants. Of the prior year quarter expense amount, the majority of the expense was related to directors and consultants.

Total expense recognized for all forms of stock-based compensation in the current nine months and prior year nine months was approximately $0.32 million and $0.17 million, respectively. Of the current nine months expense amount, approximately $0.11 million related to employees and approximately $0.21 million related to directors and consultants. Of the prior year nine months expense amount, approximately $0.02 million related to employees and approximately $0.15 million related to directors and consultants.

Stock Options

A summary of the Company’s stock options activity for the current nine months is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Remaining | ​ | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Contractual | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | Life | ​ | Intrinsic
​ |  | Options |  | Price |  | (in Years) |  | Value
Outstanding at January 1, 2024 |  | 5,148,540 | ​ | $ | 2.03 |  | 4.26 | ​ | $ | —
Granted |  | 100,000 | ​ |  | 0.85 |  |  | ​ |  |
Exercised |  | — | ​ |  | — |  |  | ​ |  |
Expired/Forfeited |  | (524,620) | ​ |  | 2.93 |  |  | ​ |  |
Outstanding at September 30, 2024, and expected to vest |  | 4,723,920 | ​ | $ | 1.90 |  | 3.90 | ​ | $ | —
Exercisable at September 30, 2024 |  | 973,920 | ​ | $ | 2.72 |  | 1.51 | ​ | $ | —

​

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

On April 3, 2024, the Company granted options to purchase an aggregate of 100,000 shares of common stock to non-management directors. The exercise price of the options is $0.85 per share, and 50% of the options vest on each of April 3, 2025 and April 3, 2026.

​

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.02 million, respectively. Compensation expense related to stock options for the current nine months and the prior year nine months was approximately $0.06 million and $0.07 million, respectively. Total unrecognized compensation expense related to unvested stock options at September 30, 2024 was approximately $0.06 million and is expected to be recognized over a weighted average period of approximately 1.07 years.

A summary of the Company’s non-vested stock options activity for the current nine months is as follows:

​

​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant Date
​ |  | Options |  | Fair Value
Balance at January 1, 2024 |  | 3,750,000 | ​ | $ | 0.04
Granted |  | 100,000 | ​ |  | 0.47
Vested |  | (100,000) | ​ | ​ | 0.90
Forfeited or Canceled |  | — | ​ |  | —
Balance at September 30, 2024 |  | 3,750,000 | ​ | $ | 0.03

​

Stock Awards

A summary of the Company’s restricted stock activity for the current nine months is as follows:

​

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted
​ | ​ | Number of | ​ | Average
​ | ​ | Restricted | ​ | Grant Date
​ |  | Shares |  | Fair Value
Outstanding at January 1, 2024 |  | 333,333 | ​ | $ | 3.69
Granted |  | 207,173 | ​ |  | 0.94
Vested |  | (167,173) | ​ |  | 0.97
Expired/Forfeited |  | — | ​ |  | —
Outstanding at September 30, 2024 |  | 373,333 | ​ | $ | 3.39

​

On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which vested immediately.

On April 3, 2024, the Company issued an aggregate of 40,000 shares of common stock to non-management directors, of which 50% shall vest on April 3, 2025, and 50% shall vest on April 3, 2026.

On July 30, 2024, the Company entered into amendments to the employment agreements dated February 27, 2019 with each of Robert W. D’Loren, its Chairman of the Board, Chief Executive Officer and President, and Seth Burroughs, its Executive Vice President of Business Development. Pursuant to each amendment, the Company agreed with the respective executive officer that commencing July 16, 2024 and ending December 31, 2025, the executive officer shall accept and the Company shall pay for each month 40% of such executive officer’s pro rata portion of Base Salary (as defined in the respective employment agreement) for each such month through the issuance of shares of the Company’s common stock. The shares of common stock will be issued on the last day of each month, and the number of shares issuable for a month to Mr. D’Loren and Mr. Burroughs shall be determined by dividing 40% of executive officer’s pro-rated Base Salary for such month by the closing sale price of the Company’s common stock on the last trading day of such month. Each of Mr.

18

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

D’Loren and Mr. Burroughs are permitted to pay the withholding tax through the exchange of a portion of the shares. As a result of these amendments, the Company issued an aggregate of 74,488 shares of common stock (which vested immediately) to executives for the current quarter and current nine months.

Also, on August 2, 2024, the Company issued 14,685 shares of common stock to a member of management, which vested immediately.

Compensation expense related to stock awards was approximately $0.13 million for the current quarter and approximately $0.03 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.26 million for the current nine months and approximately $0.10 million for the prior year nine months. Total unrecognized compensation expense related to unvested restricted stock grants at September 30, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 1.08 years.

Restricted Stock Units

There were no restricted stock units outstanding as of September 30, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At September 30, 2024, there were 2,900,118 shares of common stock available for future award grants under the 2021 Plan.

Shares Reserved for Issuance

As of September 30, 2024, there were 7,625,103 shares of common stock reserved for issuance under the Company’s Equity Incentive Plans, including 4,234,985 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 490,000 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 2,900,118 shares available for issuance under the 2021 Plan.

​

As of September 30, 2024, there were also 1,182,952 shares of common stock reserved for issuance that were unrelated to the Company’s Equity Incentive Plans, including 1,000,000 shares reserved pursuant to unexercised warrants related to the Halston Master License (as described below) and 182,952 shares reserved pursuant to unexercised Representative’s Warrants related to the March 19, 2024 Offering (as described above).

​

​

19

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

Warrants

A summary of the Company’s warrants activity for the current nine months is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Remaining | ​ | ​ | ​
​ | ​ | ​ |  | Average |  | Contractual | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise |  | Life | ​ | Intrinsic
​ |  | Warrants |  | Price |  | (in Years) |  | Value
Outstanding and exercisable at January 1, 2024 |  | 1,116,065 | ​ | $ | 1.67 |  | 8.46 | ​ | $ | —
Issued |  | 182,952 | ​ |  | 0.81 |  | ​ | ​ |  |
Exercised |  | — | ​ |  | — |  | ​ | ​ |  |
Expired/Forfeited |  | (115,000) | ​ |  | 3.17 |  | ​ | ​ |  |
Outstanding at September 30, 2024 |  | 1,184,017 | ​ | $ | 1.39 |  | 7.98 | ​ | $ | —
Exercisable at September 30, 2024 |  | 184,017 | ​ | $ | 0.81 |  | 4.44 | ​ | $ | —

​

Warrants issued during the current nine months were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current nine months related to these warrants.

In connection with the entrance into the Halston Master License (see Note 5), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recognized related to this warrant during the current quarter and prior year quarter was approximately $0.01 million in each period. The amount of contra-revenue recognized related to this warrant during the current nine months and prior year nine months was approximately $0.03 million and $0.02 million, respectively. As of September 30, 2024, no portion of this warrant had vested.

Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in any of the periods presented.

​

9. Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

​

​

20

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

The following table is a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share computations for the three and nine months ended September 30, 2024 and 2023:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | ​ | Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss attributable to Xcel Brands, Inc. stockholders (in thousands) | ​ | $ | (9,213) | ​ | $ | (5,144) | ​ | $ | (15,312) | ​ | $ | (14,255)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic weighted average number of shares outstanding |  | ​ | 23,522,453 |  | ​ | 19,749,317 | ​ | ​ | 22,466,737 |  | ​ | 19,683,525
Add: Effect of warrants |  | ​ | — |  | ​ | — | ​ | ​ | — |  | ​ | —
Add: Effect of stock options | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Diluted weighted average number of shares outstanding |  | ​ | 23,522,453 |  | ​ | 19,749,317 | ​ | ​ | 22,466,737 |  | ​ | 19,683,525
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic net income (loss) per share | ​ | $ | (0.39) | ​ | $ | (0.26) | ​ | $ | (0.68) | ​ | $ | (0.72)
Diluted net income (loss) per share | ​ | $ | (0.39) | ​ | $ | (0.26) | ​ | $ | (0.68) | ​ | $ | (0.72)

​

As a result of the net loss for all periods presented, the Company calculated diluted EPS using basic weighted average shares outstanding for all such periods, as utilizing diluted shares would be anti-dilutive to loss per share.

​

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended | ​ | Nine Months Ended
​ |  | September 30, | ​ | September 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Stock options | ​ | 4,723,920 | ​ | 5,144,170 | ​ | 4,723,920 | ​ | 5,144,170
Warrants | ​ | 1,184,017 | ​ | 1,116,065 | ​ | 1,184,017 | ​ | 1,116,065
Total | ​ | 5,907,937 |  | 6,260,235 | ​ | 5,907,937 |  | 6,260,235

​

​

​

​

​

10. Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax provision (benefit) of $0 for both periods. The effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the provision (benefit) and any deferred tax assets or liabilities that would have otherwise been recognized, as it was considered not more likely than not that any net operating losses generated during each period will be utilized in future periods.

​

The estimated annual effective income tax rate for the current nine months and the prior year nine months was approximately 0% for both periods, resulting in an income tax provision (benefit) of $0 for both periods. The effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the provision (benefit) that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

21

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

​

11. Related Party Transactions

IM Topco, LLC

As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Service Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company agreed to provide certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023. In April 2024, the services agreement was further amended to set the service fees at $150,000 per year beginning with the fiscal year ending December 31, 2024. In addition, under the April 2024 amendment, IM Topco is required to prepay the service fees for the year ending December 31, 2025; as of September 30, 2024, IM Topco has prepaid $62,500 of such service fees.

​

In accordance with the terms of this services agreement (as amended), the Company recognized service fee income of $0 and $150,000 for the three and nine months ended September 30, 2023, respectively, and service fee income of $37,500 and $112,500 for the three and nine months ended September 30, 2024, respectively. Such service fee income is reflected within net licensing revenue in the condensed consolidated statements of operations.

​

License Agreement

​

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

​

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three and nine months ended September 30, 2023, the estimated amount of such shortfall was approximately $105,000 and $225,000, respectively, which the Company recognized as royalty expense in the condensed consolidated statements of operations. Royalties received by IM Topco from the third party agreement are expected to exceed the guaranteed royalties that IM Topco would have received under the Mary 31, 2022 agreement for the year ending December 31, 2024.

​

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the following 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. During the current quarter and current nine months, the Company paid $137,500 and $237,500 to IM Topco. As of September 30, 2024, the remaining payments due totaled $137,500, which will be paid during the three months ending December 31, 2024 and are

22

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

reflected within accounts payable, accrued expenses and other current liabilities in the condensed consolidated balance sheets.

​

Financing Transactions

​

Public Offering and Private Placement Transactions

​

In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 8 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

​

Debt Refinancing

​

In connection with the December 2024 refinancing of the Company’s term loan debt, IPX Capital, LLC (“IPX”), a company controlled by Mr. D’Loren, made a $250,000 advance to one of the Company’s subsidiaries, of which $200,000 was repaid to IPX upon the closing of the debt refinancing transaction. Additionally, IPX purchased a 12.5% undivided, last-out, subordinated participation interest in a portion of the new term loan debt for a purchase price of $500,000, and received a pro rata share of warrants received by the Term B Lenders to purchase shares of the Company’s common stock. See Note 13 for additional details.

​

Guarantee

​

In October 2024, in connection with a required increase to a standby letter of credit associated with the Company’s real estate lease for offices located at 1333 Broadway, Mr. D’Loren provided a personal guarantee to the financial institution providing such letter of credit, in order to satisfy a portion of the associated collateral requirements for the letter of credit.

​

​

​

23

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

12. Commitments and Contingencies

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company.

In November 2023, this agreement was initially amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024.

On April 12, 2024, this agreement was further amended such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. This amendment also provided that if IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%.

Prior to the current quarter, no amount was recorded on the Company’s consolidated balance sheets related to this contingent obligation.

During the current quarter, management concluded that, based on current trends in and projections of IM Topco’s royalty revenues, the Company would likely be required to make such transfer of equity interests to WHP after March 31, 2025. As such, the Company estimated and recorded a contingent obligation of $6.3 million as a reduction to the carrying value of the equity method investment in the accompanying condensed consolidated balance sheet as of September 30, 2024, and recognized a corresponding non-cash charge in the condensed consolidated statements of operations for the current quarter and current nine months (see Note 2 for additional details).

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company had agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein Brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein Brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023. Based on the performance of the Lori Goldstein Brand through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which would have been paid out in 2024. During the first quarter of 2024, the Company paid approximately $0.3 million of the $1.0 million earned.

During the current nine months, as a result of the divestiture of the Lori Goldstein Brand (as described in Note 3), the seller waived their rights with respect to the Lori Goldstein Earn-Out amounts that had been previously earned and had not yet been paid, and terminated their rights to any future payments under the Lori Goldstein Earn-Out. As a result, the Company de-recognized approximately $1.03 million of accrued Lori Goldstein Earn-Out payments and the remaining

24

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

balance of approximately $5.05 million of contingent obligations recorded on the Company’s balance sheet. As of September 30, 2024, there are no liability amounts remaining on the Company’s balance sheet related to the Lori Goldstein Earn-Out.

Legal Matters

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

​

In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

​

​

13. Subsequent Events

​

Debt Refinancing

​

On December 12, 2024, the Company and certain of its subsidiaries entered into a new loan and security agreement with FEAC Agent, LLC, as administrative agent and collateral agent, FEF Distributors, LLC, as lead arranger, and Restore Capital, LLC, as agent for certain lenders, pursuant to which the lenders made term loans to the Company and agreed to make additional term loans to the Company upon the satisfaction of a condition precedent described in the loan agreement. The term loans under the loan agreement are as follows: (1) a term loan in the amount of $3.95 million (“Term Loan A”) was made on the closing date, (2) a term loan in the amount of $4.0 million (“Term Loan B”) was made on the closing date, and (3) a term loan in the amount of $2.05 million (“Delayed Draw Term Loan”; Term Loan A, Term Loan B and Delayed Draw Term Loan are referred to as “Term Loans”) which will be made upon the satisfaction of a condition precedent described in the loan agreement. The proceeds from Term Loan A and Term Loan B were used to repay the remaining balance of the Company’s October 2023 term loan with IDB, as well as to pay fees, costs, and expenses incurred in connection with entering into the new loan agreement, and the balance may be used for working capital purposes. The proceeds from the Delayed Draw Term Loan will be deposited in a bank account to satisfy a liquidity covenant in the loan agreement.

​

Principal amounts on Term Loans are payable on a pro rata basis in quarterly installments of $250,000 on each of March 31, June 30, September 30, and December 31 of each year, commencing on March 31, 2026, with the unpaid balance due at the maturity date of December 12, 2028.

​

Interest on Term Loans accrues at an annual rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to three months, subject to a 2.0% floor, plus (i) 8.5% for Term Loan A and Delayed Draw Term Loan and (ii) 13.5% for Term Loan B. Interest on amounts outstanding under the Term Loans accrues daily and is payable at the end of each calendar month.

​

The Term Loans are guaranteed by certain direct and indirect subsidiaries of the Company, and are secured by all of the asset of the Company and such subsidiaries. The loan agreement contains various customary financial covenants and reporting requirements, as specified and defined in the loan agreement.

​

In connection with the loan agreement, the Company issued warrants to purchase an aggregate of 1,456,667 shares of the Company’s common stock. These warrants have an exercise price of $0.6315 per share, are immediately exercisable, and expire on December 12, 2034.

​

25

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2024

(Unaudited)

Further, IPX Capital, LLC, a company controlled by Mr. D’Loren, purchased a 12.5% undivided, last-out, subordinated participation interest in Term Loan B for a purchase price of $500,000; IPX also received 153,333 of the aforementioned warrants, which is the pro rata share of the Term B Lenders’ warrants that were issued by the Company. Also, in October 2024, IPX made a $250,000 non-interest-bearing advance to one of the Company’s subsidiaries, of which $200,000 was repaid to IPX upon the closing of the December 12, 2024 debt refinancing transaction.

​

Shares Issued to Executives

​

On October 31, 2024, the Company issued an aggregate of 27,311 shares of common stock to executives, in accordance with the terms of the amended employment agreements with Mr. D’Loren and Mr. Burroughs (see Note 8 for details).

​

On November 30, 2024, the Company issued an aggregate of 31,372 shares of common stock to executives, in accordance with the terms of the amended employment agreements with Mr. D’Loren and Mr. Burroughs (see Note 8 for details).

​

Guarantee

​

In October 2024, in connection with a required increase to a standby letter of credit associated with the Company’s real estate lease for offices located at 1333 Broadway, Mr. D’Loren provided a personal guarantee to the financial institution providing such letter of credit, in order to satisfy a portion of the associated collateral requirements for the letter of credit.

​

​

​

​

​

26

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on April 19, 2024. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Currently, the Company’s brand portfolio consists of the following:

| ● | the Halston Brand, Ripka Brand, and C Wonder Brand, which are wholly owned by the Company;

| ● | the TowerHill by Christie Brinkley brand, which is a new co-branded collaboration between Xcel and Christie Brinkley that launched in May 2024;

| ● | the Longaberger Brand, which we manage through our 50% ownership interest in Longaberger Licensing, LLC; and

| ● | the Isaac Mizrahi Brand, in which we hold a 30% noncontrolling interest and continue to contribute to the operations of the brand through a service agreement.

Our brand portfolio also included the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”) as a wholly owned brand from April 1, 2021 through June 30, 2024; the Lori Goldstein Brand was divested on June 30, 2024.

The Company also currently owns a 30% interest in ORME Live Inc., a short-form video and social commerce marketplace that launched in April 2024.

Xcel continues to pioneer a true omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Our brands have generated over $5 billion in retail sales via live streaming in interactive television and digital channels alone, and our brands collectively reach over 5 million social media followers through Facebook, Instagram, and TikTok. All of the followers may not be unique followers, as many followers may follow multiple brands and follow our brands on multiple platforms.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

| ● | distribution and/or licensing of our brands for sale through interactive television (e.g., QVC, HSN, The Shopping Channel, JTV, etc.);

| ● | licensing of our brands to retailers that sell to the end consumer;

27

Table of Contents

| ● | direct-to-consumer distribution of our brands through e-commerce and live streaming;

| ● | licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels; and

| ● | acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

| ● | our management team, including our officers’ and directors’ experience in, and relationships within the industry;

| ● | our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;

| ● | our design, sales, marketing, and technology platform that enables us to design trend-right product; and

| ● | our significant media and internet presence.

Summary of Operating Results

Three months ended September 30, 2024 (the “current quarter”) compared with the three months ended September 30, 2023 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased $0.73 million to $1.91 million from $2.64 million for the prior year quarter.

This decrease was primarily attributable to a $0.87 million reduction in net licensing revenue, which declined from $2.38 million in the prior year quarter to $1.51 million in the current quarter, and was mainly driven by the June 30, 2024 divestiture of the Lori Goldstein Brand, partially offset by increased licensing revenues generated by our other brands.

In the current quarter, we recognized $0.41 million of net product sales from the sale of all remaining inventory of the Longaberger Brand to a third party at cost. As of September 30, 2024, we had no remaining inventory. Prior year quarter net product sales of $0.26 million represent the direct-to-consumer sales operations related to the Longaberger Brand, prior to our outsourcing of that business in the fourth quarter of 2023.

Cost of Goods Sold

Current quarter cost of goods sold was $0.41 million, as we sold all remaining inventory related to the Longaberger Brand to a third party during the current quarter, at cost.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $2.79 million, from $5.62 million in the prior year quarter to $2.83 million in the current quarter. This decrease was primarily attributable to the 2023 restructuring and transformation of our business operating model, along with additional cost reduction actions taken by management in the current year, which have significantly reduced the Company’s payroll, operating, and overhead costs. As of the third quarter of 2024, the Company has reduced its direct operating expenses to a current run rate of approximately $11 million per annum.

28

Table of Contents

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense decreased approximately $0.77 million, from $1.68 million in the prior year quarter to $0.91 million in the current quarter. This decrease is primarily attributable to the June 30, 2024 divestiture of the Lori Goldstein Brand, which included trademarks related to that brand with a net book value of approximately $1.93 million at the time of the divestiture.

We recognized equity method losses related to our equity investments in unconsolidated affiliates (IM Topco, LLC and Orme Live Inc.) of $0.59 million and $0.52 million for the current quarter and prior year quarter, respectively, due to the operations of those businesses and the distribution provisions applicable to each. The equity method losses for each quarter related to IM Topco, LLC consisted of $0.52 million of amortization expense of the Isaac Mizrahi intellectual property assets.

We also recognized a $6.25 million non-cash charge in the current quarter to recognize the estimated value of our contingent obligation to transfer a portion of our equity ownership interests in IM Topco, LLC to WHP after March 31, 2025. This charge essentially represents a subsequent reduction of the previously-recognized gain from the 2022 sale of a majority interest in the Isaac Mizrahi Brand.

Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both periods, the effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

​

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $9.21 million for the current quarter, compared with a net loss of $5.14 million for the prior year quarter, due to the combination of the factors outlined above.

Non-GAAP Net Income (Loss), Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $1.33 million, or $0.06 per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $3.05 million, or $0.15 per diluted share, for the prior year quarter. Non-GAAP net income (loss) is a non-GAAP unaudited term, which we define as net income (loss) attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, income (loss) from equity method investments, changes in ownership interests of equity method investments, stock-based compensation and cost of licensee warrants, gains on sales of assets and investments, gain on lease termination, asset impairment charges, and income taxes (if any). Non-GAAP net income (loss) and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(1.05) million for the current quarter, compared with approximately $(1.41) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders before asset impairment charges, depreciation and amortization, income (loss) from equity method investments, changes in ownership interests of equity method investments, interest and finance expenses (including loss on extinguishment of debt, if any), accretion of lease liability for exited leases, income taxes (if any), other state and local franchise taxes, stock-based compensation and cost of licensee warrants, gains on sales of assets and investments, gain on lease termination, costs of restructuring of operations, and losses from discontinued businesses.

Management uses non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends

29

Table of Contents

relating to the Company’s results of operations. Management believes non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended
​ | ​ | September 30,
($ in thousands) |  | 2024 |  | 2023
Net loss attributable to Xcel Brands, Inc. stockholders | ​ | $ | (9,213) | ​ | $ | (5,144)
Amortization of trademarks | ​ |  | 875 | ​ |  | 1,520
Loss from equity method investments | ​ | ​ | 593 | ​ | ​ | 515
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 6,254 | ​ | ​ | —
Stock-based compensation and cost of licensee warrants | ​ |  | 158 | ​ |  | 62
Non-GAAP net loss | ​ | $ | (1,333) | ​ | $ | (3,047)

​

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | September 30,
​ |  | 2024 |  | 2023
Diluted loss per share | ​ | $ | (0.39) | ​ | $ | (0.26)
Amortization of trademarks | ​ |  | 0.04 | ​ |  | 0.08
Loss from equity method investments | ​ | ​ | 0.02 | ​ | ​ | 0.03
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 0.26 | ​ | ​ | —
Stock-based compensation and cost of licensee warrants | ​ |  | 0.01 | ​ |  | 0.00
Non-GAAP diluted EPS | ​ | $ | (0.06) | ​ | $ | (0.15)
Non-GAAP weighted average diluted shares | ​ |  | 23,522,453 | ​ |  | 19,749,317

​

​

30

Table of Contents

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | September 30,
($ in thousands) |  | 2024 |  | 2023
Net loss attributable to Xcel Brands, Inc. stockholders | ​ | $ | (9,213) | ​ | $ | (5,144)
Depreciation and amortization | ​ |  | 910 | ​ |  | 1,677
Loss from equity method investments | ​ | ​ | 593 | ​ | ​ | 515
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 6,254 | ​ | ​ | —
Interest and finance expense (income) | ​ |  | 142 | ​ |  | —
Accretion of lease liability for exited lease | ​ | ​ | 98 | ​ | ​ | —
State and local franchise taxes | ​ |  | 9 | ​ |  | 9
Stock-based compensation and cost of licensee warrants | ​ |  | 158 | ​ |  | 62
Costs associated with restructuring of operations | ​ | ​ | — | ​ | ​ | 1,471
Adjusted EBITDA | ​ | $ | (1,049) | ​ | $ | (1,410)

​

Nine months ended September 30, 2024 (the “current nine months”) compared with the nine months ended September 30, 2024 (the “prior year nine months”)

​

Revenues

Current nine months net revenue decreased approximately $8.42 million to $7.05 million from $15.47 million for the prior year nine months.

This decline was primarily attributable to the $7.90 million decrease in net product sales from $8.44 million in the prior year nine months to $0.54 million in the current nine months, due to the exit from our wholesale apparel and fine jewelry sales operations and outsourcing of our Longaberger business as part of the restructuring and transformation of our business operating model in 2023. The only net product sales in the current nine months were related to the final sale of certain residual jewelry inventories and the sale of all remaining inventory related to the Longaberger brand; as of September 30, 2024, the Company has no remaining inventory.

Net licensing revenues also decreased, from $7.03 million in the prior year nine months to $6.52 million in the current nine months. This decline of approximately $0.51 million was primarily attributable to the June 30, 2024 divestiture of the Lori Goldstein Brand, partially offset by licensing revenues from the new licensing agreements with best-in-class business partners that we entered into in 2023, most notably the Halston Master License with G-III Apparel Group, as well as significantly increased revenues generated by the C Wonder by Christian Siriano business on HSN.

Cost of Goods Sold

Current nine months cost of goods sold was $0.45 million, compared with $6.72 million for the prior year nine months. This decrease was driven by the aforementioned exit from our wholesale and direct-to-consumer operations as part of the 2023 business model restructuring.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $7.86 million from $17.77 million in the prior year nine months to $9.91 million in the current nine months. This decrease was primarily attributable to the 2023 restructuring and transformation of our business operating model, which included reductions in staffing levels as well as related reductions in other overhead costs.

31

Table of Contents

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense decreased approximately $1.22 million, from $5.26 million in the prior year nine months to $4.04 million in the current nine months. This decrease is primarily attributable to the June 30, 2024 divestiture of the Lori Goldstein Brand, which included trademarks related to that brand with a net book value of approximately $1.93 million at the time of the divestiture.

Equity method losses related to our equity investments in unconsolidated affiliates (IM Topco, LLC and Orme Live Inc.) were $1.68 million and $1.55 million for the current nine months and prior year nine months, respectively, due to the operations of those businesses and the distribution provisions applicable to each. The equity method losses for each nine-month period related to IM Topco, LLC consisted of $1.55 million of amortization expense of the Isaac Mizrahi intellectual property assets.

We also recognized a $6.25 million non-cash charge in the current nine months to recognize the estimated value of our contingent obligation to transfer a portion of our equity ownership interests in IM Topco, LLC to WHP after March 31, 2025. This charge essentially represents a subsequent reduction of the previously-recognized gain from the 2022 sale of a majority interest in the Isaac Mizrahi Brand.

During the current nine months, we recognized a $3.80 million gain on the divestiture of the Lori Goldstein Brand. The consideration received from this transaction was non-cash in nature, and consisted of approximately $6.08 million of relief from certain accrued earn-out payments and the release of contingent obligations under contractual agreements with the buyer. The net book value of the intangible assets sold was approximately $1.93 million, and we also incurred approximately $0.35 million of legal fees in connection with the sale.

Also during the current nine months, we recognized asset impairment charges of approximately $3.48 million related to our exit from and sublease of our offices at 1333 Broadway, of which approximately $3.1 million related to the operating lease right-of-use asset and approximately $0.4 million related to leasehold improvements at that location.

During the prior year nine months, we recognized a gain of $0.35 million related to the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016, and a gain of $0.44 million related to a lease termination settlement with the landlord of our former retail store location.

Income Taxes

The estimated annual effective income tax rate for the current nine months and the prior year nine months was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both periods, the effective tax rate differed from the federal statutory rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

​

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $15.31 million for the current nine months, compared with a net loss of $14.26 million for the prior year nine months, due to the combination of the factors outlined above.

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $3.44 million, or $0.15 per diluted share for the current nine months and a non-GAAP net loss of $8.66 million, or $0.44 per diluted share, for the prior year nine months. We had Adjusted EBITDA of approximately $(2.66) million for the current nine months, compared with approximately $(4.57) million for the prior year nine months.

​

32

Table of Contents

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Nine Months Ended
​ | ​ | September 30,
($ in thousands) |  | 2024 |  | 2023
Net loss attributable to Xcel Brands, Inc. stockholders | ​ | $ | (15,312) | ​ | $ | (14,255)
Amortization of trademarks | ​ |  | 3,914 | ​ |  | 4,565
Loss from equity method investments | ​ | ​ | 1,683 | ​ | ​ | 1,545
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 6,254 | ​ | ​ | —
Stock-based compensation and cost of licensee warrants | ​ |  | 344 | ​ |  | 184
Gains on sales of assets and investments | ​ | ​ | (3,801) | ​ | ​ | (351)
Gain on lease termination | ​ | ​ | — | ​ | ​ | (445)
Asset impairment charges | ​ | ​ | 3,483 | ​ | ​ | 100
Non-GAAP net loss | ​ | $ | (3,435) | ​ | $ | (8,657)

​

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended
​ | ​ | September 30,
​ |  | 2024 |  | 2023
Diluted loss per share | ​ | $ | (0.68) | ​ | $ | (0.72)
Amortization of trademarks | ​ |  | 0.17 | ​ |  | 0.23
Loss from equity method investments | ​ | ​ | 0.07 | ​ | ​ | 0.08
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 0.28 | ​ | ​ | —
Stock-based compensation and cost of licensee warrants | ​ |  | 0.02 | ​ |  | 0.01
Gains on sales of assets and investments | ​ | ​ | (0.17) | ​ | ​ | (0.02)
Gain on lease termination | ​ | ​ | — | ​ | ​ | (0.02)
Asset impairment charges | ​ | ​ | 0.16 | ​ | ​ | 0.00
Non-GAAP diluted EPS | ​ | $ | (0.15) | ​ | $ | (0.44)
Non-GAAP weighted average diluted shares | ​ |  | 22,466,737 | ​ |  | 19,683,525

​

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended
​ | ​ | September 30,
($ in thousands) |  | 2024 |  | 2023
Net loss attributable to Xcel Brands, Inc. stockholders | ​ | $ | (15,312) | ​ | $ | (14,255)
Asset impairment charges | ​ |  | 3,483 | ​ |  | 100
Depreciation and amortization | ​ |  | 4,044 | ​ |  | 5,260
Loss from equity method investments | ​ | ​ | 1,683 | ​ | ​ | 1,545
Reduction in equity ownership of IM TopCo, LLC | ​ | ​ | 6,254 | ​ | ​ | —
Interest and finance expense | ​ |  | 438 | ​ |  | 18
Accretion of lease liability for exited lease | ​ | ​ | 174 | ​ | ​ | —
State and local franchise taxes | ​ |  | 33 | ​ |  | 53
Stock-based compensation and cost of licensee warrants | ​ |  | 344 | ​ |  | 184
Gains on sales of assets and investments | ​ | ​ | (3,801) | ​ | ​ | (351)
Gain on lease termination | ​ | ​ | — | ​ | ​ | (445)
Costs associated with restructuring of operations | ​ | ​ | — | ​ | ​ | 3,319
Adjusted EBITDA | ​ | $ | (2,660) | ​ | $ | (4,572)

​

​

33

Table of Contents

Liquidity and Capital Resources

General

As of September 30, 2024 and December 31, 2023, our unrestricted cash and cash equivalents were $0.24 million and $3.00 million, respectively. Restricted cash at September 30, 2024 (included within other assets in the condensed consolidated balance sheet) consisted of $0.7 million of cash deposited with Israel Discount Bank of New York as collateral for a standby letter of credit associated with a real estate lease; there was no restricted cash as of December 31, 2023.

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Our current “licensing plus” operating model is a working capital light business model, and generally does not require material capital expenditures. As of September 30, 2024, we have no significant commitments for future capital expenditures.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations, deferred revenue, and any contingent obligations payable in common stock) was approximately negative $0.4 million and positive $2.9 million as of September 30, 2024 and December 31, 2023, respectively. Post closing of the new term loan debt in December 2024 (as described further below), the Company’s working capital increased by approximately $4.5 million.

Liquidity and Management’s Plans

We incurred a net loss attributable to Company stockholders of approximately $15.3 million during the nine months ended September 30, 2024 (which included non-cash expenses of approximately $15.8 million, and a non-cash gain of approximately $3.8 million on the divestiture of the Lori Goldstein Brand), and had an accumulated deficit of approximately $69.2 million as of September 30, 2024. Net cash used in operating activities was approximately $3.3 million for the nine months ended September 30, 2024. These factors, along with our current levels of cash and working capital, raise uncertainties about the Company’s ability to continue as a going concern.

​

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. These restructuring initiatives included entering into various new licensing agreements and joint venture arrangements with best-in-class business partners, and reducing the Company’s payroll, overhead, and other operating costs by approximately $15 million on an annualized basis when compared to 2022.

During the first nine months of 2024, management took further actions to optimize its cost structure and manage its liquidity, including entering into a divestiture transaction (see Note 3 for details) which eliminated certain operating and compensation expenses, relieved the Company of its contractual obligations to make future cash payments of approximately $1 million, and relieved the Company of a potential future contingent obligation to make future cash payments of up to approximately $11 million. As of the third quarter of 2024, the Company has reduced its direct operating expenses to a current run rate of approximately $11 million per annum. Also during the first nine months of 2024, the Company issued new shares of common stock for net proceeds of approximately $2 million. Further, in December 2024, the Company entered into a new term loan agreement for the aggregate amount of $10 million.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of September 30, 2024 have been alleviated.

​

34

Table of Contents

Commentary on the components of our cash flows for the current nine months as compared with the prior year nine months is set forth below.

Operating Activities

Net cash used in operating activities was approximately $3.31 million in the current nine months, compared with approximately $2.81 million in the prior year nine months.

The current nine months net cash used in operating activities was primarily attributable to the combination of the net loss of $(15.40) million plus non-cash items of approximately $11.99 million and the net change in operating assets and liabilities of approximately $0.11 million. Non-cash items were primarily comprised of approximately $6.25 million for the change in value of contingent obligations, $4.04 million of depreciation and amortization expense, $3.48 million of asset impairment charges, and our $1.68 million undistributed proportional share of net losses from equity method investees, partially offset by a $(3.80) million gain on the divestiture of the Lori Goldstein Brand. The net change in operating assets and liabilities was primarily comprised of decreases in accounts receivable and inventory of approximately $0.59 million and $0.45 million, respectively, partially offset by a decrease in lease-related assets and liabilities of $(0.71) million.

The prior year nine months cash used in operating activities was primarily attributable to the combination of the net loss of $(15.04) million plus non-cash items of approximately $7.07 million and the net change in operating assets and liabilities of approximately $5.16 million. Non-cash items were primarily comprised of $5.26 million of depreciation and amortization expense, our $1.55 million undistributed proportional share of net loss of equity method investee, and a $0.76 million charge related to the restructuring of certain contractual arrangements, partially offset by a $(0.35) gain on the sale of a financial asset and a $(0.44) gain on the settlement of a lease liability. The net change in operating assets and liabilities was primarily comprised of (i) an increase in deferred revenue of approximately $4.68 million, which was mainly attributable to the upfront payment received for the Halston Master License agreement entered into during the prior year nine months, (ii) a decrease in inventory of approximately $1.85 million, driven by the sale of all of our C Wonder apparel inventory to HSN and the sale of all of our Judith Ripka fine jewelry inventory to JTV, as part of the restructuring and transformation of our business operating model. Partially offsetting these net changes in operating assets and liabilities were decreases in various operating liabilities of approximately $(1.40) million.

Investing Activities

Net cash used in investing activities in the current nine months was comprised of purchases of furniture and fixtures totaling approximately $0.11 million.

Net cash provided by investing activities in the prior year nine months was approximately $0.36 million, primarily driven by $0.45 million of proceeds received from the sale of a limited partner ownership interest in an unconsolidated affiliate, which was entered into in 2016.

Financing Activities

Net cash provided by financing activities in the current nine months was primarily attributable to $1.90 million of net proceeds generated by equity issuance transactions undertaken during the first quarter (as described in more detail below), partially offset by $0.50 million of scheduled principal payments made on our term loan debt.

Net cash provided by financing activities in the prior year nine months was entirely attributable to proceeds from the exercise of employee stock options in the amount of approximately $0.03 million

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

35

Table of Contents

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi brand, we agreed with WHP (the buyer) that, in the event that IM Topco, LLC receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from us up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by us in either cash or equity interests in IM Topco, LLC held by us.

In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. No amount has been recorded in the Company’s condensed consolidated balance sheets related to this contingent obligation.

In April 2024, the Company, WHP, and IM Topco, LLC entered into an amendment to this agreement, such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. Additionally, the parties agreed that if IM Topco, LLC royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco, LLC to WHP, such that Xcel’s ownership interest in IM Topco, LLC would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco, LLC would increase from 70% to 82.5%.

Prior to the current quarter, no amount was recorded on the Company’s consolidated balance sheets related to this contingent obligation. However, during the current quarter, management concluded that, based on current trends in and projections of IM Topco’s royalty revenues, the Company would likely be required to make such transfer of equity interests to WHP after March 31, 2025. As such, the Company estimated and recorded a contingent obligation of $6.25 million as a reduction to the carrying value of the equity method investment in the accompanying condensed consolidated balance sheet as of September 30, 2024.

​

36

Table of Contents

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, we agreed to pay the seller additional cash consideration of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein Brand and the total consideration paid.

As of December 31, 2022, based on the performance of the Lori Goldstein Brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023. Based on the performance of the Lori Goldstein Brand through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which would have been paid out in 2024. During the first quarter of 2024, the Company paid approximately $0.3 million of the $1.0 million earned.

During the current nine months, as a result of the divestiture of the Lori Goldstein Brand, the seller waived their rights with respect to the Lori Goldstein Earn-Out amounts that had been previously earned and had not yet been paid, and terminated their rights to any future payments under the Lori Goldstein Earn-Out. As a result, the Company de-recognized approximately $1.03 million of accrued Lori Goldstein Earn-Out payments and the remaining balance of approximately $5.05 million of contingent obligations recorded on the Company’s balance sheet. As of September 30, 2024, there are no liability amounts remaining on the Company’s balance sheet related to the Lori Goldstein Earn-Out.

Debt Refinancing

​

On December 12, 2024, the Company and certain of its subsidiaries entered into a new loan and security agreement with FEAC Agent, LLC, as administrative agent and collateral agent, FEF Distributors, LLC, as lead arranger, and Restore Capital, LLC, as agent for certain lenders, pursuant to which the lenders made term loans to the Company and agreed to make additional term loans to the Company upon the satisfaction of a condition precedent described in the loan agreement. The term loans under the loan agreement are as follows: (1) a term loan in the amount of $3.95 million (“Term Loan A”) was made on the closing date, (2) a term loan in the amount of $4.0 million (“Term Loan B”) was made on the closing date, and (3) a term loan in the amount of $2.05 million (“Delayed Draw Term Loan”; Term Loan A, Term Loan B and Delayed Draw Term Loan are referred to as “Term Loans”) which will be made upon the satisfaction of a condition precedent described in the loan agreement. The proceeds from Term Loan A and Term Loan B were used to repay the remaining balance of the Company’s October 2023 term loan with IDB, as well as to pay fees, costs, and expenses incurred in connection with entering into the new loan agreement, and the balance may be used for working capital purposes. The proceeds from the Delayed Draw Term Loan will be deposited in a bank account to satisfy a liquidity covenant in the loan agreement.

​

Principal amounts on Term Loans are payable on a pro rata basis in quarterly installments of $250,000 on each of March 31, June 30, September 30, and December 31 of each year, commencing on March 31, 2026, with the unpaid balance due at the maturity date of December 12, 2028.

​

Interest on Term Loans accrues at an annual rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to three months, subject to a 2.0% floor, plus (i) 8.5% for Term Loan A and Delayed Draw Term Loan and (ii) 13.5% for Term Loan B. Interest on amounts outstanding under the Term Loans accrues daily and is payable at the end of each calendar month.

​

The Term Loans are guaranteed by certain direct and indirect subsidiaries of the Company, and are secured by all of the asset of the Company and such subsidiaries. The loan agreement contains various customary financial covenants and reporting requirements, as specified and defined in the loan agreement.

​

In connection with the loan agreement, the Company issued warrants to purchase an aggregate of 1,456,667 shares of the Company’s common stock. These warrants have an exercise price of $0.6315 per share, are immediately exercisable, and expire on December 12, 2034.

​

37

Table of Contents

Further, IPX Capital, LLC (“IPX”), a company controlled by Robert W. D’Loren, Chairman and Chief Executive Officer of the Company, purchased a 12.5% undivided, last-out, subordinated participation interest in Term Loan B for a purchase price of $500,000; IPX also received 153,333 of the aforementioned warrants. Also, in October 2024, IPX made a $250,000 non-interest-bearing advance to one of the Company’s subsidiaries, of which $200,000 was repaid to IPX upon the closing of the December 12, 2024 debt refinancing transaction

​

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Halston brand, C Wonder brand, and TowerHill by Christie Brinkley brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business, and the Longaberger brand focuses on home good products, which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

While the 2022 sale of a majority interest in the Isaac Mizrahi brand resulted in a decrease in our licensing revenues, as that brand represented a significant portion of our historical licensing revenues, we have taken and continue to take actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, and additional domestic and international licensing arrangements, and acquiring and collaborating with additional brands, including the C Wonder by Christian Siriano business on HSN, and the recently-launched TowerHill by Christie Brinkley brand.

During 2023, we restructured our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing plus” business model. These efforts included entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks. These restructuring initiatives were originally expected to provide us with approximately $15 million of cost savings on an annualized basis compared to our previous operating model. Based on additional actions taken by management during the first nine months of 2024 and the recent divestiture of the Lori Goldstein brand, the Company’s direct operating costs on an annualized basis have been reduced from approximately $8 million per quarter under our previous operating model to approximately $2.5 to $3.0 million per quarter on a going-forward basis. This represents approximately $21 million of cost savings on an annualized basis compared to our cost structure in 2022.

Nonetheless, we continue to face a number of headwinds in the current macroeconomic environment. Poor economic and market conditions, including the impacts of recent inflation and rising consumer debt levels, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation and/or a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

38

Table of Contents

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 19, 2024, for a discussion of our critical accounting policies and estimates. During the three and nine months ended September 30, 2024, there were no material changes to our critical accounting policies or estimates.

​

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

​

ITEM 4. CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2024, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2024, due to the material weakness described below.

The basis for the conclusion that such internal control was ineffective included the following considerations:

| ● | The Company was unable to file its Annual Report on Form 10-K within the time specified in SEC rules and forms, due to a failure to obtain audited financial statements of the Company’s investment in an equity method investee. Additional procedures were required for the Company’s audit, which impacted on the resources required to timely file the Company’s Form 10-K.

| ● | During the middle of February 2024, our equity method investee (IM Topco, LLC) engaged an independent audit firm (separate from Marcum, LLP) to conduct its audit. We agreed to pay for all fees of the audit, and on February 23, 2024, paid a retainer to the audit firm, in accordance with the engagement. The audit firm was the same firm which conducted the audit for the year ended December 31, 2022 for the same equity method investee and delivered timely such audited financial statements for such prior audit. However, the audit firm for the equity method investee has not completed the 2023 audit on a timely basis. It was determined their progress was significantly deficient, and there would not be sufficient time to engage a new audit firm to receive timely, audited financial statements of the equity method investee. The determination was made by IM Topco, LLC to terminate this firm’s 2023 engagement and engage Marcum LLP to provide the 2023 audited financial statements. This engagement is separate from and independent of services that Marcum LLP provides to Xcel.

39

Table of Contents

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

40

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

​

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

ITEM 1A. RISK FACTORS

​

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

​

There is a high likelihood that we will be obligated to transfer an additional 12.5% of IM Topco to WHP as we do not expect IM Topco to meet revenue targets set forth in the purchase agreement.

​

In accordance with the May 31, 2022 membership interest purchase agreement, as amended, WHP (as buyer) may be entitled to receive from Xcel 12.5% of the total outstanding equity interests of IM Topco if, during the twelve-month period ending March 31, 2025, IM Topco receives less than $13.5 million in aggregate royalties (the “Purchase Price Adjustment”). Based on current trends and projections of IM Topco’s revenues, the Company estimates that there is high likelihood that IM Topco’s revenues will be less than the required minimum and the Company will be obligated to transfer the required membership interests to WHP in accordance with the Purchase Price Adjustment. The Company has recorded a contingent obligation of approximately $6.3 million as a reduction to the carrying value of the equity method investment as of September 30, 2024, based on the expected March 31, 2025 value of the potential transferred membership interest. If such transfer occurs, our interest in the equity of IM Topco will be reduced from 30% to 17.5%.

​

Our existing and any future indebtedness could adversely affect our ability to operate our business.

​

On December 12, 2024, we and certain of our subsidiaries entered into a new loan and security agreement with FEAC Agent, LLC, as administrative agent and collateral agent, FEF Distributors, LLC, as lead arranger, and Restore Capital, LLC, as agent for certain lenders, pursuant to which the lenders made term loans to us and agreed to make additional term loans to us upon the satisfaction of a condition precedent described in the loan agreement. The term loans under the loan agreement are as follows: (1) a term loan in the amount of $3.95 million (“Term Loan A”) was made on the closing date, (2) a term loan in the amount of $4.0 million (“Term Loan B”) was made on the closing date, and (3) a term loan in the amount of $2.05 million (“Delayed Draw Term Loan”; Term Loan A, Term Loan B and Delayed Draw Term Loan are referred to as “Term Loans”) which will be made upon the satisfaction of a condition precedent described in the loan agreement. The proceeds from the Delayed Draw Term Loan were deposited in a bank account to satisfy a liquidity covenant in the loan agreement.

Principal amounts on Term Loans are payable on a pro rata basis in quarterly installments of $250,000 on each of March 31, June 30, September 30, and December 31 of each year, commencing on March 31, 2026, with the unpaid balance due at the maturity date of December 12, 2028. Interest on Term Loans accrues at an annual rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to three months, subject to a 2.0% floor, plus (i) 8.5% for Term Loan A and Delayed Draw Term Loan and (ii) 13.5% for Term Loan B. Interest on amounts outstanding under the Term Loans accrues daily and is payable at the end of each calendar month.

41

Table of Contents

The Term Loans are guaranteed by certain of our direct and indirect subsidiaries, and are secured by all of the assets of the Company and such subsidiaries. The loan agreement contains various customary financial covenants and reporting requirements, as specified and defined in the loan agreement, including minimum revenue requirements and an approximately $2.05 million minimum liquidity requirement. In addition, we are required to raise at least $1,500,000 of equity capital by March 31, 2025. If we do not raise the equity capital, the reserve for the liquidity covenant will increase to approximately $4.05 million and the minimum revenue requirements will increase by 12.5%.

Our outstanding indebtedness, including any additional indebtedness beyond our borrowings under the loan agreement, combined with our other financial obligations and contractual commitments could have significant adverse consequences, including:

| ● | Requiring us to dedicate a portion of our cash resources to the payment of interest and principal, reducing money available to fund working capital, capital expenditures, potential acquisitions, international expansion, new product development, new enterprise relationships, and other general corporate purposes;

| ● | Increasing our vulnerability to adverse changes in general economic, industry, and market conditions;

| ● | Subjecting us to restrictive covenants that may reduce our ability to take certain corporate actions or obtain further debt or equity financing;

| ● | Limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which we compete; and

| ● | Placing us at a competitive disadvantage compared to our competitors that have less debt or better debt servicing options.

We intend to satisfy our current and future debt service obligations with our then existing cash and cash equivalents. However, we may not have sufficient funds, and may be unable to arrange for additional financing, to pay the amounts due under the loan agreement or any other debt instruments. Failure to make payments or comply with other covenants under our existing loan agreement or such other debt instruments could result in an event of default and acceleration of amounts due, which would have a material adverse effect on our business.

A breach of the covenants under the loan agreement could result in an event of default under the applicable indebtedness. An event of default under the loan agreement could permit the lenders under the loan agreement to terminate all commitments to extend further credit under the loan agreement. Furthermore, if we were unable to repay the amounts due and payable under the loan agreement, those lenders could proceed against the collateral granted to them to secure that indebtedness. In the event our lender accelerates the repayment of our borrowings, we may not have sufficient assets to repay that indebtedness.

ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

​

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

​

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

​

42

Table of Contents

ITEM 5. OTHER INFORMATION

In October 2024, in connection with a required increase to a standby letter of credit associated with the Company’s real estate lease for offices located at 1333 Broadway, Robert W. D’Loren, Chairman and Chief Executive Officer of the Company, provided a personal guarantee to the financial institution providing such letter of credit, in order to satisfy a portion of the associated collateral requirements for the letter of credit.

​

In connection with the refinancing of the Company’s term loan debt in December 2024, IPX Capital, LLC (“IPX”), a company controlled by Mr. D’Loren, purchased a 12.5% undivided, last-out, subordinated participation interest in a portion of the new term loan debt for a purchase price of $500,000. As part of this refinancing transaction, IPX also received 153,333 warrants to purchase shares of the Company’s common stock, with such warrants having an exercise price of $0.6315 per share, being immediately exercisable, and expiring on December 12, 2034.

​

Also, in October 2024, IPX made a $250,000 non-interest-bearing advance to one of the Company’s subsidiaries, of which $200,000 was repaid to IPX upon the closing of the December 2024 debt refinancing transaction.

​

ITEM 6. EXHIBITS

The following exhibits are filed herewith:

​
31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)
31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)
32.1 Section 1350 Certification (CEO) *
32.2 Section 1350 Certification (CFO) *
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

​

* Furnished herewith.

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 20, 2024 | By: | /s/ Robert W. D’Loren
|  | Name: Robert W. D’Loren
|  | Title: Chairman and Chief Executive Officer
| By: | /s/ James F. Haran
|  | Name: James F. Haran
|  | Title: Chief Financial Officer and Vice President

​

​

​

43